Keyword: Excipients

Plant Construction & Process Technology

The EXCiPACT Certification Scheme

27.09.2017 - There is a regulatory expectation that pharmaceutical companies will verify that the excipients produced by their suppliers are to an appropriate level of GMP. This has been...

News

Roquette to Launch New Biopharmaceutical Brands

15.03.2017 - French family-owned group Roquette plans to introduce three new brands to address the growing demand for excipients and raw materials for the biopharmaceutical market. The new...

News

Omya Opens Laboratory in Switzerland

21.03.2016 - Swiss specialty chemicals producer and distributor Omya has opened a new pharmaceutical and nutraceutical laboratory at its headquarters in Oftringen, gaining the capability to...

News

DKSH and DFE Pharma Sign Distribution Agreement for Eight European Countries

10.03.2015 - DKSH's Business Unit Performance Materials has been appointed exclusive Market Expansion Services partner for DFE Pharma's Pharmacel MCC excipient for France, Switzerland, UK...

News

CPhI Worldwide Announces International Advisory Board

21.01.2015 - CPhI Worldwide has announced the launch of a new advisory board, consisting of the following industry experts who provide a wide expertise portfolio: Alan Sheppard, Principal...

Plant Construction & Process Technology

The EXCiPACT Certification Scheme

05.10.2014 - Excipients, together with an active pharmaceutical ingredient (API), are formulated into a final drug that is either prescribed to a patient by a doctor or bought over-the-counter...

Chemistry & Life Sciences

The Art of Adding Value

10.09.2013 - Balancing Act - Regulatory hurdles and product quality are not just challenges reserved for speciality chemical companies; chemical distributors must also adhere to the highest...

Plant Construction & Process Technology

Recombinant Human Albumin

14.06.2012 - Modern Excipients - Traditionally, excipients have never received the same attention as that given to the Active Pharmaceutical ingredient (API). Instead they have been seen as...